Maynard Um
-
-
-
-
-
-
-
Emergent BioSolutions (EBS) Misses Q1 EPS by 65c
-
-
-
-
-
-
-
Emergent BioSolutions partners with British Columbia for naloxone program
-
-
-
-
-
-
-
Emergent BioSolutions gets $21.5 million contract for anthrax vaccine
-
-
-
-
-
-
-
Emergent BioSolutions gets $17 million contract for smallpox drug
-
-
-
-
-
-
-
Emergent BioSolutions (EBS) Secures $62.4M Contract Modification for BAT
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Emergent BioSolutions (EBS)
-
-
-
-
-
-
-
H.C. Wainwright Starts Emergent BioSolutions (EBS) at Buy
-
444,513 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

